Correlation Between Bluebird Bio and Zentalis Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Bluebird Bio and Zentalis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bluebird Bio and Zentalis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bluebird bio and Zentalis Pharmaceuticals Llc, you can compare the effects of market volatilities on Bluebird Bio and Zentalis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bluebird Bio with a short position of Zentalis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bluebird Bio and Zentalis Pharmaceuticals.

Diversification Opportunities for Bluebird Bio and Zentalis Pharmaceuticals

-0.08

Correlation Coefficient

Bluebird Bio  Zentalis Pharmaceuticals

Good diversification

The 3 months correlation between Bluebird and Zentalis is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Bluebird bio and Zentalis Pharmaceuticals Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zentalis Pharmaceuticals and Bluebird Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bluebird bio are associated (or correlated) with Zentalis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zentalis Pharmaceuticals has no effect on the direction of Bluebird Bio i.e., Bluebird Bio and Zentalis Pharmaceuticals go up and down completely randomly.

Pair Corralation between Bluebird Bio and Zentalis Pharmaceuticals

Given the investment horizon of 90 days Bluebird bio is expected to generate 4.14 times more return on investment than Zentalis Pharmaceuticals. However, Bluebird Bio is 4.14 times more volatile than Zentalis Pharmaceuticals Llc. It trades about 0.09 of its potential returns per unit of risk. Zentalis Pharmaceuticals Llc is currently generating about -0.14 per unit of risk. If you would invest  38.00  in Bluebird bio on September 14, 2024 and sell it today you would earn a total of  0.00  from holding Bluebird bio or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Bluebird bio  vs.  Zentalis Pharmaceuticals Llc

Bluebird bio

Risk-Adjusted Performance

1 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Bluebird bio are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Bluebird Bio exhibited solid returns over the last few months and may actually be approaching a breakup point.

Zentalis Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Zentalis Pharmaceuticals Llc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Zentalis Pharmaceuticals is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Bluebird Bio and Zentalis Pharmaceuticals

The main advantage of trading using opposite Bluebird Bio and Zentalis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bluebird Bio position performs unexpectedly, Zentalis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zentalis Pharmaceuticals will offset losses from the drop in Zentalis Pharmaceuticals' long position.

The idea behind Bluebird bio and Zentalis Pharmaceuticals Llc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.